Clinical Trials

Showing trials with last updates posted in 2025.

NCT06365216 | ACTIVE_NOT_RECRUITING | PHASE2
80 participants

ALS Phase II Study of NX210c

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-24
Start Date:
2024-10-25
Completion:
2026-02-01
Conditions
  • Amyotrophic Lateral Sclerosis
Interventions
  • DRUG
No Results Yet
NCT06098612 | RECRUITING | EARLY_PHASE1
40 participants

PET Imaging Evaluation of [11C]SY08

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-24
Start Date:
2024-05-01
Completion:
2026-11-30
Conditions
  • Parkinson's Disease
  • Multiple System Atrophy
  • Dementia With Lewy Bodies
  • Healthy Controls
Interventions
  • DRUG
No Results Yet
NCT06022029 | RECRUITING | PHASE1
168 participants

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

Study Type:
INTERVENTIONAL
Last Updated:
2025-12-24
Start Date:
2023-10-13
Completion:
2026-04-30
Conditions
  • Triple Negative Breast Cancer
  • Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Lymphoma, Non-Hodgkin
  • Mantle Cell Lymphoma
  • Bladder Cancer
  • Uveal Melanoma, Recurrent
  • Cervix Cancer
  • Carcinoma in Situ
  • Head and Neck Squamous Cell Carcinoma
  • Skin Cancer
  • Metastatic Cancer
  • Tumor, Solid
  • Tumor Recurrence
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page